PebbleAtlas
PEBBLE / ATLAS
Open research access
PRECLINICAL PUBLICATION · 2012

Zerumbone attenuates the severity of acute necrotizing pancreatitis and pancreatitis-induced hepatic injury.

Rat / Chemical/toxin

Evidence by therapy association

Study details and outcomes are extracted in the context of a specific intervention. Separate associations are retained rather than silently merged.

PMID 22529518 ↗2012Reported benefit

Zerumbone attenuates the severity of acute necrotizing pancreatitis and pancreatitis-induced hepatic injury.

RatChemical/toxinWistarMalen = Preliminary study 8 per group; formal study taurocholate an…Intravenous via femoral vein10 mg/kg, selected from a preliminary dose-ranging study of…30 minutes before induction of pancreatitis (pretreatment)

Model: Acute necrotizing pancreatitis induced by retrograde biliary-pancreatic duct infusion of 5% sodium taurocholate, with secondary hepatic injury

Zerumbone pretreatment significantly reduced serum amylase, sPLA2, ALT and AST and improved pancreatic and hepatic histopathology, inhibited NF-kappaB and downregulated ICAM-1 and IL-1beta mRNA. In the preliminary study neither 5 nor 40 mg/kg improved sPLA2 and ALT, and 10 mg/kg was the minimum eff…

Extraction: extract · Supplied extraction confidence: 0.9. Machine-extracted fields require source verification.